Page last updated: 2024-10-26

pentetic acid and Myofibromatosis

pentetic acid has been researched along with Myofibromatosis in 1 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Myofibromatosis: A condition characterized by multiple formations of myofibromas (LEIOMYOMA).

Research Excerpts

Excerpt	Relevance	Reference
"Infantile myofibromatosis is a rare clinical entity characterized by multiple mesenchymal tumors in the neonatal period."	1.29	Multicentric infantile myofibromatosis in the cranium: case report. ( Hasegawa, M; Kida, S; Takakuwa, S; Yamashima, T; Yamashita, J, 1995)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hasegawa, M	1
Kida, S	1
Yamashima, T	1
Yamashita, J	1
Takakuwa, S	1

Clinical Trials (1)

Trial Overview

Trial			Phase	Enrollment	Study Type	Start Date	Status
Adjunct Targeted Biologic Inhibition in Children With Multivessel Intraluminal Pulmonary Vein Stenosis[NCT00891527]			Phase 1/Phase 2	50 participants (Actual)	Interventional	2008-10-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Patients With Disease Progression at 48 Weeks

"Patients will be classified as having disease progression if at least 2 pulmonary veins have significantly worsened at 48 weeks. This determination is based on the study defined Pulmonary Vein Status Scale, which categorizes pulmonary veins on a scale from 1- None: No narrowing of the luminal contour, to 7- Distal atretic: Complete obliteration of the luminal contour extending >5mm within the vessel segment." (NCT00891527)
Timeframe: 48 weeks

Intervention	Participants (Count of Participants)
Avastin and/or Gleevec	5

Number of Patients With Disease Stabilization at 48 Weeks

(NCT00891527)
Timeframe: 48 weeks

Intervention	Participants (Count of Participants)
Avastin and/or Gleevec	15

Number of Patients With Survival at 48 Weeks

(NCT00891527)
Timeframe: 48 weeks

Intervention	Participants (Count of Participants)
Avastin and/or Gleevec	42

Other Studies

1 other study available for pentetic acid and Myofibromatosis

Article	Year
Multicentric infantile myofibromatosis in the cranium: case report. Neurosurgery, 1995, Volume: 36, Issue:6 Topics: Contrast Media; Craniotomy; Dura Mater; Female; Gadolinium DTPA; Humans; Infant; Myofibromatosis; Oc	1995